Sodium-channel inhibitors produced by enteropathogenic Vibrio cholerae and Aeromonas hydrophila.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 2436014)

Published in Lancet on April 25, 1987

Authors

M L Tamplin, R R Colwell, S Hall, K Kogure, G R Strichartz

Articles citing this

Cholera. Clin Microbiol Rev (1995) 12.33

Contemporary issues: diseases with a food vector. Clin Microbiol Rev (1988) 1.31

Case studies in cholera: lessons in medical history and science. Yale J Biol Med (2001) 0.81

Cholera and severe toxigenic diarrhoeas. Gut (1994) 0.75

Articles by these authors

DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature (2000) 19.93

Survival strategies of bacteria in the natural environment. Microbiol Rev (1987) 18.16

A tentative direct microscopic method for counting living marine bacteria. Can J Microbiol (1979) 15.31

Virioplankton: viruses in aquatic ecosystems. Microbiol Mol Biol Rev (2000) 12.84

Ecology of Vibrio parahaemolyticus in Chesapeake Bay. J Bacteriol (1973) 11.24

Emerging marine diseases--climate links and anthropogenic factors. Science (1999) 10.22

Ecology, serology, and enterotoxin production of Vibrio cholerae in Chesapeake Bay. Appl Environ Microbiol (1979) 9.51

Vibrio parahaemolyticus from the blue crab Callinectes sapidus in Chesapeake Bay. Science (1969) 8.08

Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol (1983) 7.52

Vibrio cholerae, Vibrio parahaemolyticus, and other vibrios: occurrence and distribution in Chesapeake Bay. Science (1977) 6.86

The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J Gen Physiol (1973) 6.49

Viable but nonrecoverable stage of Salmonella enteritidis in aquatic systems. Can J Microbiol (1984) 6.32

Occurrence of Vibrio cholerae serotype O1 in Maryland and Louisiana estuaries. Appl Environ Microbiol (1981) 5.95

Viable but nonculturable stage of Campylobacter jejuni and its role in survival in the natural aquatic environment. Appl Environ Microbiol (1986) 5.66

Microbial degradation of hydrocarbons in the environment. Microbiol Rev (1990) 5.42

Simple, rapid method for direct isolation of nucleic acids from aquatic environments. Appl Environ Microbiol (1989) 5.26

Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03

Influence of water temperature, salinity, and pH on survival and growth of toxigenic Vibrio cholerae serovar 01 associated with live copepods in laboratory microcosms. Appl Environ Microbiol (1984) 4.87

Influence of salinity and organic nutrient concentration on survival and growth of Vibrio cholerae in aquatic microcosms. Appl Environ Microbiol (1982) 4.52

Adsorption of Vibrio parahaemolyticus onto chitin and copepods. Appl Microbiol (1975) 4.43

Vibrio parahaemolyticus and related halophilic Vibrios. Crit Rev Microbiol (1982) 4.24

Effects of temperature and salinity on Vibrio cholerae growth. Appl Environ Microbiol (1982) 4.19

Bacteria associated with the surface and gut of marine copepods. Appl Environ Microbiol (1979) 3.89

Attachment of Vibrio cholerae serogroup O1 to zooplankton and phytoplankton of Bangladesh waters. Appl Environ Microbiol (1990) 3.73

Polyphasic taxonomy of the genus vibrio: numerical taxonomy of Vibrio cholerae, Vibrio parahaemolyticus, and related Vibrio species. J Bacteriol (1970) 3.68

Survival and viability of nonculturableEscherichia coli andVibrio cholerae in the estuarine and marine environment. Microb Ecol (1982) 3.60

Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol (1990) 3.41

Distribution of viruses in the Chesapeake Bay. Appl Environ Microbiol (1992) 3.36

Detection of Vibrio cholerae O1 in the aquatic environment by fluorescent-monoclonal antibody and culture methods. Appl Environ Microbiol (1990) 3.21

Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int (2007) 3.17

Association of Aeromonas sobria with human infection. J Clin Microbiol (1981) 3.17

Distribution and significance of fecal indicator organisms in the Upper Chesapeake Bay. Appl Microbiol (1975) 2.99

Distribution of viable marine bacteria in neritic seawater around Japan. Can J Microbiol (1980) 2.87

Molecular mechanisms of local anesthesia: a review. Anesthesiology (1990) 2.82

Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke (1995) 2.81

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation (1999) 2.78

Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) (1985) 2.78

Adsorption kinetics of laterally and polarly flagellated Vibrio. J Bacteriol (1982) 2.74

Aeromonas primary wound infection of a diver in polluted waters. J Clin Microbiol (1979) 2.72

Metabolic activity of bacterial cells enumerated by direct viable count. Appl Environ Microbiol (1987) 2.67

Enumeration of Vibrio cholerae O1 in Bangladesh waters by fluorescent-antibody direct viable count. Appl Environ Microbiol (1987) 2.65

El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect (2009) 2.60

Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial. Ann Rheum Dis (2004) 2.54

Medium for the presumptive identification of Aeromonas hydrophila and Enterobacteriaceae. Appl Environ Microbiol (1979) 2.49

Distribution of Vibrio parahaemolyticus and related organisms in the Atlantic Ocean off South Carolina and Georgia. Appl Microbiol (1974) 2.45

Global spread of microorganisms by ships. Nature (2000) 2.43

Biochemical characteristics and virulence of environmental group F bacteria isolated in the United States. Appl Environ Microbiol (1980) 2.42

Aeromonas hydrophila: ecology and toxigenicity of isolates from an estuary. J Appl Bacteriol (1981) 2.42

Genotypes associated with virulence in environmental isolates of Vibrio cholerae. Appl Environ Microbiol (2001) 2.41

Effects of temperature and salinity on the survival of Vibrio vulnificus in seawater and shellfish. Appl Environ Microbiol (1993) 2.40

Microbial petroleum degradation: use of mixed hydrocarbon substrates. Appl Microbiol (1974) 2.39

Functionally different GPI proteins are organized in different domains on the neuronal surface. EMBO J (1999) 2.35

Assignment of tra cistrons to EcoRI fragments of F sex factor DNA. J Bacteriol (1978) 2.32

Association of multiple-antibiotic-resistance profiles with point and nonpoint sources of Escherichia coli in Apalachicola Bay. Appl Environ Microbiol (1997) 2.32

Adansonian analysis of the Rhizobiaceae. J Gen Microbiol (1968) 2.30

Morphology and round body fermation in Vibrio marinus. J Bacteriol (1969) 2.28

Extractable lipids of gram-negative marine bacteria: phospholipid composition. J Bacteriol (1973) 2.27

Effects of microcosm salinity and organic substrate concentration on production of Vibrio cholerae enterotoxin. Appl Environ Microbiol (1986) 2.25

Discriminant analysis of ribotype profiles of Escherichia coli for differentiating human and nonhuman sources of fecal pollution. Appl Environ Microbiol (1999) 2.25

Neurotoxic shellfish poisoning and brevetoxin metabolites: a case study from Florida. Toxicon (2000) 2.24

Analysis of 16S-23S rRNA intergenic spacer regions of Vibrio cholerae and Vibrio mimicus. Appl Environ Microbiol (1999) 2.23

Polyphasic taxonomy of the genus Vibrio: polynucleotide sequence relationships among selected Vibrio species. J Bacteriol (1970) 2.21

Virulence genes in environmental strains of Vibrio cholerae. Appl Environ Microbiol (2000) 2.21

Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy. Neurology (2011) 2.20

Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med (2001) 2.19

Viable but nonculturable bacteria in drinking water. Appl Environ Microbiol (1991) 2.17

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology (2010) 2.16

Deliberate self-harm in Oxford, 1990-2000: a time of change in patient characteristics. Psychol Med (2003) 2.16

Use of autoradiography to assess viability of Helicobacter pylori in water. Appl Environ Microbiol (1993) 2.16

Antibiotic resistance indexing of Escherichia coli to identify sources of fecal contamination in water. Can J Microbiol (1990) 2.14

The fate of enteric pathogenic bacteria in estuarine and marine environments. Microbiol Sci (1986) 2.11

Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol (1996) 2.10

The binding of labelled saxitoxin to the sodium channels in nerve membranes. J Physiol (1973) 2.10

Enumeration of petroleum-degrading microorganisms. Appl Environ Microbiol (1976) 2.09

Incidence of Vibrio parahaemolyticus in Chesapeake Bay. Appl Microbiol (1975) 2.07

Seasonality of Chesapeake Bay bacterioplankton species. Appl Environ Microbiol (2002) 2.07

Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and Spain. Ann Oncol (2012) 2.07

Evidence that tetrodotoxin and saxitoxin act at a metal cation binding site in the sodium channels of nerve membrane. Proc Natl Acad Sci U S A (1974) 2.06

Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum (1990) 2.03

Marine vibrios associated with bacillary necrosis, a disease of larval and juvenile bivalve mollusks. J Bacteriol (1970) 2.01

Plasmids carried by antibiotic-resistant marine bacteria. Antimicrob Agents Chemother (1977) 1.95

Measuring the potential activity of hydrocarbon-degrading bacteria. Appl Environ Microbiol (1976) 1.94

A simple filtration method to remove plankton-associated Vibrio cholerae in raw water supplies in developing countries. Appl Environ Microbiol (1996) 1.93

Ambient-temperature primary nonselective enrichment for isolation of Salmonella spp. from an estuarine environment. Appl Environ Microbiol (1977) 1.92

Communication deficits and aggression in the mentally retarded. Am J Ment Defic (1971) 1.88

Isolation, enumeration, and characterization of Aeromonas from polluted waters encountered in diving operations. Appl Environ Microbiol (1980) 1.88

Marine ecosystems. Lancet (1993) 1.88

Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87

A new method for labelling saxitoxin and its binding to non-myelinated fibres of the rabbit vagus, lobster walking leg, and garfish olfactory nerves. J Physiol (1976) 1.86

Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates. Appl Environ Microbiol (2001) 1.86

Deep-sea bacteria: growth and utilization of hydrocarbons at ambient and in situ pressure. Appl Microbiol (1974) 1.86

Evaluation of the accuracy and precision of enumerating aerobic heterotrophs in water samples by the spread plate method. Appl Environ Microbiol (1978) 1.86

Some effects of petroleum on estuarine and marine microorganisms. Can J Microbiol (1975) 1.85

Voltage-dependent blockade of muscle Na+ channels by guanidinium toxins. J Gen Physiol (1984) 1.84

Nucleotide base sequence of vibrionaceae 5 S rRNA. FEBS Lett (1984) 1.83

Nuclease S1 analysis of eubacterial 5S rRNA secondary structure. J Mol Evol (1985) 1.82

Characterization of plasmids in bacterial fish pathogen. Infect Immun (1983) 1.82